Skip to content
Monday, 16 November 2026Vol. 1 · No. 9 · Price: one objection
The Object Daily

We object. On principle.

Subject

health

2 objections so far. We have not yet found anything about health that we agree with.

Science10 Nov 2026Disagreement: 2 out of 5, unconvinced

The FDA's new eye warning should be printed in letters large enough to be read

The regulator has told the makers of Ozempic, Wegovy and similar drugs to warn of a rare risk to vision. The warning is right. The font is the problem.

Everyone else: The FDA's new warning about rare vision loss on GLP-1 drugs is a sensible, overdue precaution that patients and doctors should take seriously.

Related to health

All topics →